CHANNEL THERAPEUTICS CORPORA (CHRO)
Institutional ownership reported to the SEC as of Q2 2025, across 6 quarters.
5
Reporting holders
$187.3K
Reported value
0.0%
Held as options
-4
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | $172.3K | 136,712 | 0.00% | new | NEW |
| GEODE CAPITAL MANAGEMENT, LLC | $14.1K | 10,435 | 0.00% | 2q | +3.6% |
| UBS Group AG | $822 | 652 | 0.00% | 2q | -34.5% |
| Tower Research Capital LLC (TRC) | $107 | 85 | 0.00% | 5q | -96.7%-$3.1K |
| BANK OF AMERICA CORP /DE/ | $24 | 19 | 0.00% | 5q | +58.3% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2025 | 5 | $187.3K | 147,903 | 1 | 2 | 2 | 0.0% |
| Q1 2025 | 9 | $846.2K | 595,899 | 6 | 1 | 0 | 0.0% |
| Q4 2024 | 4 | $16.0K | 25,012 | 0 | 1 | 2 | 0.0% |
| Q3 2024 | 5 | $59.6K | 83,936 | 3 | 2 | 0 | 0.0% |
| Q2 2024 | 5 | $290.3K | 219,945 | 4 | 0 | 1 | 0.0% |
| Q1 2024 | 1 | $659.9K | 251,888 | 1 | 0 | 0 | 0.0% |